PrEP

Latest News

Can Monoclonal Antibodies Prevent COVID-19? Assessing Cost-Effectiveness in a High-Risk Population
Can Monoclonal Antibodies Prevent COVID-19? Assessing Cost-Effectiveness in a High-Risk Population

July 7th 2023

In a comprehensive economic evaluation, researchers assessed the cost-effectiveness of monoclonal antibodies as a preventive strategy for COVID-19.

Disparities in HIV Prevention: New Data Reveal Racial and Regional Gaps in PrEP Usage
Disparities in HIV Prevention: New Data Reveal Racial and Regional Gaps in PrEP Usage

June 28th 2023

Does HIV Status Affect Tecovirimat Treatment Efficacy in Mpox Patients?
Does HIV Status Affect Tecovirimat Treatment Efficacy in Mpox Patients?

May 2nd 2023

HIV/AIDS Treatments Advance, But Stigma Remains a Major Obstacle
HIV/AIDS Treatments Advance, But Stigma Remains a Major Obstacle

February 7th 2023

Drugs Commonly Used to Treat HIV and HBV May Reduce Immune Cells’ Energy
Drugs Commonly Used to Treat HIV and HBV May Reduce Immune Cells’ Energy

January 19th 2023

More News

© 2024 MJH Life Sciences

All rights reserved.